WHO and St. Jude Children’s research hospital to dramatically increase global access to childhood cancer medicine

The global platform for access to childhood cancer medicines

Cancer medicine shortages for children around the world

Allogeneic haematopoietic cell transplantation in adults with Ph-like ALL

Axicabtagene ciloleucel vs standard‑of‑care therapy for relapsed/refractory large B-cell lymphoma

Dara-CVRd, V-ASCT and Dara-Vrd Consolidation in UHiR NDMM and pPCL compared with myeloma XI/XI+ Trial treatment for Uhir MM

Monoclonal antibody-based quadruplet therapy, AHCT and MRD response-adapted consolidation therapy gives highest rate of MRD negativity in NDMM

Antibody and T-cell responses to COVID-19 vaccination in myeloproliferative neoplasm patients

Allogeneic CAR-T PBCAR0191 with intensified lymphodepletion is highly active in pts with relapsed/refractory B-cell malignancies

Mosunetuzumab induces deep and durable remissions in 3L R/R follicular lymphoma

Post-HSCT management of ALL - Adult ALL perspective

Safety profile of BiTE therapy